Amneal Pharmaceuticals, Inc. (AMRX) NASDAQ
12.65
-0.25(-1.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.95B |
| Enterprise Value | 6.37B |
| P/E Ratio | 34.01 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.32 |
| Price/Book Ratio | -91.63 |
| Enterprise/Revenue | 2.15 |
| Enterprise/EBITDA | 10.44 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.12 |
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | -1.45 |
Income Statement
| Revenue | 3.02B |
| Revenue/Share | 9.26 |
| Gross Profit | 1.14B |
| EBITDA | 603.87M |
| Net Income | 72.06M |
| Diluted EPS | 0.22 |
Balance Sheet
| Total Cash | 197.66M |
| Total Cash/Share | 0.6 |
| Total Debt | 2.7B |
| Total Debt/Equity | -59.38 |
| Current Ratio | 2.47 |
| Book Value Per Share | -0.14 |
Price History
| 52-Week Change | 70.49 |
| 52-Week High | 15.42 |
| 52-Week Low | 7.07 |
| Moving Average 50 Days | 12.65 |
| Moving Average 200 Days | 12.03 |
Statistics
| Average Volume | 1.81M |
| Shares Outstanding | 319.02M |
| % Held by Institutions | 51.02 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
